MS
Mandeep Singh
About Mandeep Singh
Data last updated:
Mandeep Singh is a Director at Alenvision Pharma Private Limited (since 2024), Director at Indmark Biotech Private Limited (since 2021) and Additional Director at Alenrise Retail Private Limited (since 2024). The companies operate in Pharma and Food and Beverages. The 3 current companies with reported revenue have a combined latest revenue of ₹12.11 Cr; the largest is Alenvision Pharma Private Limited at ₹11.01 Cr (FY 2025). Earlier, Mandeep Singh was an Additional Director at Anvicure Drugs Private Limited (2024).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Alenvision Pharma Private Limited U24100MH2020PTC340540 | Director | 29 Mar 2024 | 2020 | ₹11.01 Cr (FY 2025) | Active |
 Indmark Biotech Private Limited U24290HR2021PTC097637 | Director | 13 Sep 2021 | 2021 | ₹1.03 Cr (FY 2025) | Active |
| Alenrise Retail Private Limited U52110HR2021PTC095931 | Additional Director | 29 Mar 2024 | 2021 | ₹6.5 Lakh (FY 2024) | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Anvicure Drugs Private Limited U74999HP2019PTC007326 | Additional Director | 26 Mar 2024 | 2019 | ₹2.88 Cr (FY 2024) | Active |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Mandeep Singh
| Name | DIN | Company | Designation |
|---|---|---|---|
| Rajesh Kumar | 11242071 | Alenvision Pharma Private Limited | Director |
| Naresh Kumar | 09317476 | Indmark Biotech Private Limited | Director |
| Sujata | 08441301 | Alenrise Retail Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Mandeep Singh
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Mandeep Singh
Mandeep Singh currently holds 3 directorships: Alenvision Pharma Private Limited (Director, since 29 Mar 2024, revenue ₹11.01 Cr (FY 2025)); Indmark Biotech Private Limited (Director, since 13 Sep 2021, revenue ₹1.03 Cr (FY 2025)); Alenrise Retail Private Limited (Additional Director, since 29 Mar 2024, revenue ₹6.5 Lakh (FY 2024)).
Mandeep Singh was first appointed on 13 Sep 2021 as Director at Indmark Biotech Private Limited. The most recent appointment on record is 29 Mar 2024 at Alenrise Retail Private Limited.
The 3 current companies of Mandeep Singh that report revenue have a combined latest revenue of ₹12.11 Cr: Alenvision Pharma Private Limited ₹11.01 Cr (FY 2025); Indmark Biotech Private Limited ₹1.03 Cr (FY 2025); Alenrise Retail Private Limited ₹6.5 Lakh (FY 2024).
Mandeep Singh held 1 earlier board appointment: Anvicure Drugs Private Limited (Additional Director, 26 Mar 2024 to 24 Aug 2024).
The current boards of Mandeep Singh's companies include Rajesh Kumar (Alenvision Pharma Private Limited), Naresh Kumar (Indmark Biotech Private Limited), Sujata (Alenrise Retail Private Limited).